Latest news with #TSXV
Yahoo
an hour ago
- Business
- Yahoo
Rakovina Therapeutics Announces Share Consolidation Effective Date
VANCOUVER, British Columbia, June 20, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) ('Rakovina' or the 'Company') is pleased to announce that the effective date for the previously announced share consolidation (the 'Consolidation') will be June 24, 2025. As outlined in the Company's news release dated May 15, 2025, the Consolidation will be conducted on the basis of one (1) post-consolidation common share ('Post-Consolidation Share') for every ten (10) pre-consolidation common shares ('Pre-Consolidation Share'). The Post-Consolidation Shares are scheduled to begin trading on the TSX Venture Exchange (the 'TSX-V') at the market open on June 24, 2025 under the existing symbol 'RKV'. Following the Consolidation, the new CUSIP number for the common shares will be 75103L309 and the new ISIN number will be CA75103L3092. No fractional shares will be issued as a result of the Consolidation. Any fractional interest in shares resulting from the Consolidation will be rounded up to the next whole share if the fraction is one-half or greater, and down if the fraction is less than one-half. In all other respects, the Post-Consolidation Shares will have the same attributes as the Pre-Consolidation shares. Following the Consolidation, the Company will have approximately 21,148,038 common shares issued and outstanding. The exercise or conversion price and the number of common shares issuable under any of the Company's outstanding warrants, stock options and convertible debentures, as applicable, will be proportionately adjusted to reflect the Consolidation in accordance with their respective terms. The Company's transfer agent, Odyssey Trust Company ('Odyssey'), will mail a letter of transmittal to registered shareholders of the Company providing instructions on exchanging Pre-Consolidation Share certificates for Post-Consolidation Share certificates or Direct Registration System (DRS) advices. Shareholders are encouraged to send their share certificates, together with their letter of transmittal, to Odyssey in accordance with the instructions in the letter of transmittal. Until surrendered, each share certificate (or DRS advice) representing Pre-Consolidation Shares will be deemed to represent the number of whole Post-Consolidation Shares to which the shareholder is entitled as a result of the Consolidation. The Consolidation remains subject to the final approval of the TSX-V. Additional details regarding the Consolidation can be found in the Company's news release dated May 15, 2025 available under the Company's profile on SEDAR+ at The TSX-V has neither approved nor disapproved the content of this press release. Neither the TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release. About Rakovina Therapeutics Inc. Rakovina Therapeutics is a biopharmaceutical research company focused on the development of innovative cancer treatments. Our work is based on unique technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, we can review and optimize drug candidates at a much greater pace than ever before. The Company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Further information may be found at press release may contain "forward-looking statements" regarding the Company and its respective business within the meaning of applicable Canadian securities laws, including, without limitations, statements regarding: the Company's objectives, goals or future plans regarding its cancer treatments or proposed business plan; expected results of the Company's DDR platform; the timing and completion of the Consolidation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. Often, but not always, forward-looking statements can be identified by the use of words such as 'plans', 'is expected', 'expects', 'scheduled', 'intends', 'contemplates', 'anticipates', 'believes', 'proposes' or variations (including negative variations) of such words and phrases, or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. The forward-looking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks regarding the medical device industry, economic factors, regulatory factors, the equity markets generally and risks associated with growth and competition. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events, or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. The reader is referred to the Company's most recent filings on SEDAR+ for a more complete discussion of all applicable risk factors and their potential effects, copies of which may be accessed through the Company's profile page at For Further Information Contact:Michelle Seltenrich, BSc MBADirector, Corporate DevelopmentIR@ in to access your portfolio
Cision Canada
2 hours ago
- Business
- Cision Canada
Reklaim Expands 'Protect' to Include California Opt-Outs, Ad Tech Removal, and Family Protection
Subscribers' data is now automatically removed from California-registered data brokers, as well as enterprise and DSP platforms TORONTO, June 20, 2025 /CNW/ - Reklaim Ltd. (TSXV: MYID) (OTC: MYIDF) ("Reklaim" or the "Company"), a leader in consumer data privacy and compliant data monetization, today announced a significant update to Reklaim Protect, its privacy subscription service that helps users shrink their digital footprint. With this latest release, Reklaim Protect now automatically removes subscriber data from companies listed in California's official data broker registry, as well as enterprise data platforms and demand-side platforms (DSP s) used in digital advertising. These new capabilities further strengthen Reklaim's position as a privacy-first alternative for consumers who want to opt out of the data economy and reduce the availability of their information for sale, targeting, or unauthorized use. "Removing your data from these platforms is about cutting off the source," said Neil Sweeney, Founder and CEO of Reklaim. "Brokers, fraudsters, and bad actors all rely on the same data supply to power their models. If you don't proactively reduce your footprint, your information remains exposed and in circulation. By integrating the California registry, we're cutting subscribers off from one of the largest data pipelines in the world." Key Features of Reklaim Protect (V2) California Data Broker Registry Opt-Out Reklaim subscribers' data is now automatically removed from data brokers listed in California's official registry, the largest of its kind in the world, with a single digital signature inside the Reklaim app. This step leverages state privacy laws to disconnect consumers from some of the most active and persistent data sellers in the U.S. View the official registry ➝ Enterprise & DSP Data Removal Reklaim now facilitates opt-outs from enterprise data platforms and demand-side platforms (DSPs) used by advertisers to profile and target consumers, helping reduce unwanted surveillance and behavioural tracking. Family-Wide Monitoring Protect Subscribers, who are also members of Reklaim Rewards, can also monitor up to 10 verified email addresses for dark web breaches, extending protection to family members and close contacts. These enhancements build on the original features of Reklaim Protect, which include: Reklaim Protect is available to Reklaim subscribers in Canada and the United States, offering a 14-day free trial and ongoing access for just $1/month or $10/year. The service is fully integrated into the Reklaim mobile and web app experience.
Miami Herald
3 hours ago
- Business
- Miami Herald
Organto Foods Announces Final Settlement of Convertible Debenture Obligations
VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ("Organto" or the "Company") is pleased to announce that, as part of its efforts to reduce debt and increase equity in the Company, it has completed the previously announced settlement (the "Settlement") of its 8.0% convertible unsecured subordinated debentures due November 30, 2026 with an aggregate face value of C$8,050,000 (the "Debentures") (see the Company's news releases dated May 1, 2025, March 30, 2025, and March 11, 2025). Under the terms of the Settlement, all outstanding Debentures (including all principal amounts and all accrued and unpaid interest owing thereunder) were exchanged for the issuance by the Company of an aggregate of 40,250,000 common shares of the Company (the "Settlement Shares") at an issue price of $0.20 per Settlement Share for an aggregate issue price of $8,050,000. Each Debenture holder received the number of Settlement Shares that is equal to the aggregate principal amount of the Debentures held by such Debenture holder divided by $0.20. The Settlement Shares are subject to contractual restrictions on transfer whereby such shares will be released over a 30-month period from June 11, 2025, being the date of issuance of the Settlement Shares (the "Issue Date") as follows: 25% of the Settlement Shares will be released on the date that is 21 months following the Issue Date;25% of the Settlement Shares will be released on the date that is 24 months following the Issue Date;25% of the Settlement Shares will be released on the date that is 27 months following the Issue Date; and25% of the Settlement Shares will be released on the date that is 30 months following the Issue Date. Steve Bromley, Chair and CEO commented "We are extremely pleased to complete the settlement of the Debentures, which aligns with our efforts to reduce debt and increase equity in the Company. Following this Settlement, the Company has approximately C$2.6 million of debt outstanding, and when combined with the recent completion of our $5.3 million private placement and our record first quarter 2025 financial results, we are truly excited by our future prospects. We remain intently committed to building a world-class foods company serving growing healthy foods markets, with the goal of creating long-term value for our operating partners, customers, team members and shareholders. We appreciate the support and understanding we have received from so many of our shareholders, debenture holders and key operating partners and are confident that we are well positioned for a successful future." Prior to completion of the Settlement, Debenture holders representing 68.89% of the outstanding principal amount of the Debentures provided written consent in favor of a resolution approving the Settlement, which exceeded the 66.7% threshold required under the trust indenture governing the Debentures. As a result, a meeting of Debenture holders to approve the Settlement was not necessary. In accordance with the terms of a Corporate Finance Advisory agreement (the "Advisory Agreement") between the Company and Jaluca Limited ("Jaluca"), the Company retained Jaluca to provide guidance and assistance in negotiating and implementing the overall restructuring of the Company, including the reduction of the Company's substantial debts and refinancing (see news release dated March 20, 2025). As disclosed in the Company's March 20, 2025 news release the Advisory Agreement provided for the payment of various fees, including a monthly fee and success-based fees. For its assistance in negotiating and implementing the Debenture restructuring and settlement, the Company agreed, subject to the approval of the TSX Venture Exchange (the "TSXV")and disinterested shareholder approval in accordance with the policies of the TSXV, to pay Jaluca a fee equal to 6% of the total amount of settled Debentures, excluding any Debentures held by Jaluca (the "Fee"). As a result, the Company has agreed to issue an aggregate of 4,380,000 common shares in the capital of the Company at a deemed issue price of $0.10 per share in full payment of this obligation. The Company plans to immediately seek shareholder approval for the issuance of these common shares. ON BEHALF OF THE BOARD Steve BromleyChairman and CEO For more information, contact:Investor RelationsJohn Rathwell, Senior Vice President, Investor Relations & Corporate Development647 629 0018info@ ABOUT ORGANTO Organto is a leading provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-lighter business model to serve a growing socially responsible and health-conscious consumers. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders. FORWARD LOOKING STATEMENTS This news release may include certain forward-looking information and statements, as defined by law, including without limitation, Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting the Company's efforts to restructure and reduce overall debt and increase equity in the Company; the Company's belief that when combined with the recently completed private placement and shares for debt settlements and record first quarter 2025 results, the Company's future is very promising; the Company's belief that its commitment to building a world class foods company should lead to the creation of long-term value; and the Company's plans to seek disinterested shareholder approval in respect of payment of the Fee through the issuance of common shares in the capital of the Company. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including, without limitation, the assumption that the Company will be able to continue to grow its operations and raise necessary financial resources to support this growth and that both disinterested shareholder approval and TSXV approval in connection with the payment of the Fee through the issuance of common shares in the capital of the Company will be obtained in a timely manner and on terms consistent with management's expectations. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in forward-looking statements in this news release include, among others, regulatory risks; risks related to market volatility and economic conditions; risks related to unforeseen delays; risks that necessary financing will be unavailable when needed; and risk that disinterested shareholders and/or TSXV approval may not be obtained in a timely manner or at all. For further information on these and other risks and uncertainties that may affect the Company's business, see the "Risks and Uncertainties" and "Forward-Looking Statements" sections of the Company's annual and interim management's discussion and analysis filings with the Canadian securities regulators, which are available under the Company's profile at Except as required by law, Organto does not assume any obligation to release publicly any revisions to forward-looking statements contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. SOURCE: Organto Foods, Inc.
Hamilton Spectator
4 hours ago
- Business
- Hamilton Spectator
Morocco Strategic Minerals Launches Maiden Drill Program on Timarighine Property
MONTRÉAL, June 20, 2025 (GLOBE NEWSWIRE) — Morocco Strategic Minerals Corporation. (TSXV: MCC) ('Morocco Strategic Minerals' or the 'Corporation') is pleased to announce the commencement of its maiden drilling program on the Timarighine property, located in the eastern Anti-Atlas region of Morocco. This follows a successful initial exploration phase which confirmed the presence of high-grade copper mineralization and a robust structural framework with potential for scale. Phase 1 Highlights The initial phase of work at Timarighine focused on trench deepening, opening new exposures, geophysical surveying, and systematic channel and grab sampling. This exploration program led to the discovery of high-grade sulphide mineralization beginning at shallow depths (8–10 metres), previously masked by surface weathering. Channel and grab samples returned exceptional copper grades of up to 16.16% Cu*, with occurrences of native copper (figure 1) and occasionally silver values reaching up to 20 g/t Ag. Mineralization is also hosted by a strongly developed dyke stockwork system, indicating the presence of a broad mineralized envelope. Additionally, arsenopyrite concentrations of up to 5,079 ppm were identified, a mineral commonly associated with gold-bearing systems. These results further support the presence of a near-surface polymetallic system and reinforce the Corporation's drill targeting strategy for the upcoming drill program. * Grab and channel samples are selective by nature and are not necessarily representative of the mineralization hosted on the property Figure 1: High-grade sulphide mineralization encountered during Phase 1 of exploration at the Timarighine property, grading up to 16.16% copper (Cu). The samples also confirmed the presence of native copper. Planned Drilling Program The maiden drill campaign at Timarighine will consist of approximately 1,300 metres of diamond drilling (DDH) and 400 metres of reverse circulation (RC) drilling, designed to systematically evaluate the project's two most prominent mineralized structures as well as the surrounding stockwork zones. The diamond drill holes will primarily target the down-dip and along-strike extensions of the high-grade sulphide veins identified during Phase 1 trenching and sampling. These holes are designed to validate the extension of the mineralized zones at depth. In parallel, eight shallow RC holes (50 metres each) will be drilled to test the broader mineralized envelope between the known structures and toward the east, where geophysical and geological indicators suggest the potential for a disseminated or stockwork-style copper system. This two-pronged approach is designed to validate the Corporation's geological model while optimizing exploration efficiency and cost-effectiveness (figure 2). The program is fully permitted, fully funded and started on June 18, 2025. Figure 2: Planned diamond drilling (DDH) targeting the two main mineralized structures identified to date, where high-grade sulphide mineralization has been observed. The program also includes reverse circulation (RC) drilling designed to test the broader stockwork system and evaluate the potential extent of mineralization beyond the primary vein structures. About the Timarighine Property The Timarighine copper prospect is located in the Tazzarine rural commune within the Tazarine caïdat, Agdez district, Zagoura province, in Morocco's Drâa-Tafilalet region. Situated approximately 13 km northwest of Tazarine village, the property lies along the southern slopes of the Jbel Saghro in the eastern Anti-Atlas, an area renowned for copper mineralization, including the nearby Oumjrane deposit. Access to the site is available via national road R108, between Nkob and Tazarine, followed by a direct track to the Timarighine area. Covering approximately 64 km², the property comprises four contiguous exploration permits (3842563, 3842734, 3842735, and 3842736). The Timarighine property lies within an east-west trending depression on the southern front of the Precambrian-aged Saghro massif. Copper mineralization occurs along two parallel vein structures, known locally as 'iron cap' zones, marked by extensive alteration zones with hematite and goethite iron oxides. The mineralized structures are characterized by a shear system oriented NNE-SSW and feature local stockwork zones of brecciated carbonate-quartz-pyrite-chalcopyrite veinlets. The two main mineralized veins extend approximately 650 meters and 300 meters in length, with variable widths up to 5 meters. High-grade copper identified within these zones also hints at significant primary sulfide mineralization potential at depth, underscoring Timarighine's status as a high-value copper exploration target. About Morocco Strategic Minerals Morocco Strategic Minerals Inc. is a Canadian mineral exploration company focused on the acquisition, exploration, and, if warranted, development of natural resource properties of merit in Canada and Morocco. Qualified Person The technical and scientific information in this press release have been reviewed by Merouane Rachidi, Ph.D., an independent qualified person as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects ('NI 43-101'). Contact Information Pierre-Olivier Goulet Vice-President Corporate Development Email: pogoulet@ 1-450-821-5270 Guy Goulet President and CEO Email: ggoulet@ 1-514-294-7000 Forward-Looking Statements and Disclaimer Certain information contained herein may constitute 'forward-looking information' under Canadian securities legislation. Generally, forward-looking information can be identified using forward-looking terminology such as 'will be,' 'expected,' or variations of such words and phrases, or statements that certain actions, events, or results 'will' occur. Forward-looking statements, including statements relating to the intended use of the net proceeds from the Offering, are based on the Corporation's estimates and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, level of activity, performance, or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Corporation will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. Figures accompanying this announcement are available at:
Cision Canada
4 hours ago
- Business
- Cision Canada
METALLIS CLOSES $1,500,000 NON-BROKERED PRIVATE PLACEMENT
VANCOUVER, BC, June 20, 2025 /CNW/ - Metallis Resources Inc. (TSXV: MTS); (OTCQB: MTLFF), (FSE: 0CVM) (the "Company" or "Metallis") announces the closing of its non-brokered private placement (the "Financing"). Details announcing the Financing can be found in the Company's previous news releases dated May 22 nd and June 6 th, 2025. Total proceeds from the Financing are $1,500,000, resulting in the issuance of 9,375,000 units at a price of $0.16 per unit. Each unit consists of one common share and one non-transferable share purchase warrant entitling the holder to purchase one additional common share at a price of $0.26 per share for a 3-year period. Proceeds from the Financing will be used for field exploration work at the Company's Greyhound and Kirkham properties and for general corporate purposes. All shares issued on closing are subject to a regulatory trading hold period expiring four months plus one day from date of issuance. Finder fees of $42,720 along with 267,000 finder's warrants, also exercisable at a price of $0.26 per share for a 3-year period, were paid to registered finders. About Metallis Metallis Resources Inc. is a Vancouver-based company focused on the exploration for gold, copper and silver on its flagship 100%-owned Kirkham Property in Canada, situated in northwest British Columbia's Golden Triangle, and on its Greyhound Property, a silver, gold and antimony target in Idaho, USA. Metallis trades under the symbols MTS on the TSX Venture Exchange, MTLFF on the OTCQB Exchange, and 0CVM on the Frankfurt Stock Exchange. With this Financing, the Company has 84,680,003 common shares outstanding. On behalf of the Board of Directors: /s/ "Fiore Aliperti" Chief Executive Officer, President, and Director CAUTION REGARDING FORWARD-LOOKING STATEMENTS This Press Release may contain statements which constitute 'forward-looking' statements, including statements regarding the plans, intentions, beliefs and current expectations of the Company, its directors, or its officers with respect to the future business activities and operating performance of the Company. The words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions, as they relate to the Company, or its management, are intended to identify such forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future business activities or performance and involve risks and uncertainties, and that the Company's future business activities may differ materially from those in the forward-looking statements because of various factors. Such risks, uncertainties and factors are described in the periodic filings with the Canadian securities' regulatory authorities, including quarterly and annual Management's Discussion and Analysis, which may be viewed on SEDAR at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as intended, planned, anticipated, believed, estimated, or expected. The Company does not intend, and does not assume any obligation, to update these forward-looking statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX-V Stock Exchange has neither approved nor disapproved the contents of this news release.
